PanBiokem

PanBiokem appears to have been a small biotechnology company focused on synthetic broad-spectrum antiviral compounds. Publicly available evidence is sparse, but the company was associated with a compound referred to as JKOR that was described in external coverage as having dose-dependent antiviral activity against multiple enveloped viruses in screening work. There is no clear evidence of an active commercial organization, clinical-stage pipeline, financing history, or ongoing operations. Based on the limited record available, PanBiokem looks like an early-stage or now-inactive biotech entity rather than an operating pharmaceutical company with an established development portfolio.